Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.
Open Access
- 1 April 1992
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 45 (4) , 332-338
- https://doi.org/10.1136/jcp.45.4.332
Abstract
AIMS: To examine the sensitivity and specificity to past thrombotic events of four different coagulation tests, which screen for lupus anticoagulant (LA), and of anticardiolipin antibodies in patients with systemic lupus erythematosus. METHODS: Fifty three consecutive patients with systemic lupus erythematosus were studied of whom three males and 21 females, aged 21-60 years, had a history of venous and arterial thrombosis, or miscarriage, or both. Activated partial thromboplastin time (aPTT), dilute Russell's viper venom time (dRVVT), kaolin clotting time (KCT), dilute aPTT and the circulating titre of anticardiolipin antibodies were investigated in the two groups of patients and in 20 healthy control subjects. RESULTS: The prolonged dilute aPTT was more sensitive to thromboses or miscarriages, or both than dRVVT (p less than 0.05), KCT (p less than 0.01), and aPTT (p less than 0.001). No significant differences in specificity were found among aPTT (100%), dRVVT (93%), KCT (93%) and dilute aPTT (86.2%); but aPTT and dRVVT were significantly more specific (p less than 0.01, p less than 0.05, respectively) than anticardiolipin antibodies. CONCLUSIONS: The study shows a strong association between lupus anticoagulant and thrombosis when a very sensitive test such as the dilute aPTT is used. The combination of this assay with a very specific test such as dRVVT might enable patients with SLE at high risk of thrombosis to be identified.Keywords
This publication has 83 references indexed in Scilit:
- Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.BMJ, 1990
- Studies on the relationship between 'antiphospholipid' antibodies and the lupus anticoagulantBlood Coagulation & Fibrinolysis, 1990
- Antiphospholipid Antibodies and Recurrent Pregnancy LossAmerican Journal of Reproductive Immunology, 1989
- Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.Annals of the Rheumatic Diseases, 1988
- Role of Lupus Anticoagulant and Autoimmunity in Recurrent Pregnancy LossSeminars in Reproductive Medicine, 1988
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 casesAmerican Journal of Hematology, 1985
- LUPUS ANTICOAGULANT IN PREGNANCYThe Lancet, 1984
- LUPUS ANTICOAGULANT AND THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1984
- A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural PatternsBritish Journal of Haematology, 1978